StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3011% above fair value
$920.69−2.65 (-0.29%)

Close on Nov 20, 2026Market cap $95.24BP/E 20.3Yield –

Regeneron Pharmaceuticals Libtayo by Quarter

Libtayo — Rest of World (ROW) Net Product Sales Recorded by Regeneron ($M) ($M)

Regeneron Pharmaceuticals Libtayo: $154M in Q3 2026, up 5.5% from a year earlier. That is the highest of the 21 quarters on record here.

Latest, Q3 2026
154
Period ended Sep 30, 2026
Change on a year earlier
+5.5%
146 in Q3 2025
History
21 quarters
Since Q3 2021
Sources
16
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q (filed 2026-10-30) ↗

Reported in Form 10-Q / 10-K Note — Net Product Sales (XBRL).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLibtayo — Rest of World (ROW) Net Product Sales Recorded by Regeneron ($M) ($M)Year on yearSource
Q3 2026Sep 30, 2026154+5.5%Form 10-Q (filed 2026-10-30) ↗
Q2 2026Jun 30, 2026147+14.1%Form 10-Q (filed 2026-07-30) ↗
Q1 2026Mar 31, 2026152+64.3%Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 2025140+21.1%Form 10-K (filed 2026-02-04) ↗
Q3 2025Sep 30, 2025146+55.3%Form 10-Q (filed 2026-10-30) ↗
Q2 2025Jun 30, 2025129+11.9%Form 10-Q (filed 2026-07-30) ↗
Q1 2025Mar 31, 202592.6-11.6%Form 10-Q (filed 2026-04-29) ↗
Q4 2024Dec 31, 2024116+30.0%Form 10-K (filed 2026-02-04) ↗
Q3 2024Sep 30, 202494.1+6.6%Form 10-Q (filed 2025-10-28) ↗
Q2 2024Jun 30, 2024115+44.1%Form 10-Q (filed 2025-08-01) ↗
Q1 2024Mar 31, 2024105+55.8%Form 10-Q (filed 2025-04-29) ↗
Q4 2023Dec 31, 202389+111.9%Form 10-K (filed 2026-02-04) ↗
Q3 2023Sep 30, 202388.3+184.8%Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 202379.8–Form 10-Q (filed 2024-08-01) ↗
Q1 2023Mar 31, 202367.2–Form 10-Q (filed 2024-05-02) ↗
Q4 2022Dec 31, 202242–Form 10-K (filed 2025-02-05) ↗

Breakdown

What makes up libtayo

Cite this data

StockData. (2026). Regeneron Pharmaceuticals Libtayo ($M), quarterly Q3 2021–Q3 2026 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/rev-libtayo-row

See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?